Aker Yards ASA to be admitted to the Main List
The Board of Oslo Børs agreed to admit shares in Aker Yards ASA to listing on the Main List of Oslo Børs. Aker Yards was exempted from the requirement for at least 25 per cent of its shares to be widely spread among the general public at the time of listing, i.e. to be held by shareholders who are not connected with the company in the manner described in Section 2-3 of the Stock Exchange Regulations. However the company is required to achieve such a distribution for its shares as quickly as possible, and in any case no later than four months after the first day of listing. Admission to listing is conditional on the management of Oslo Børs being satisfied that Aker Yards has made arrangements prior to the first day of listing to ensure that this requirement is satisfied.
The Board’s approval also requires that Aker Yards produces a prospectus that satisfies the requirements for a listing prospectus set out in the Stock Exchange Regulations. The Board authorised the President of Oslo Børs to decide the date of the first day of listing, which is to be no later than 16 June 2004.
About Aker Yards
Aker Yards is an international shipbuilding group focusing on complex and sophisticated vessels and is Europe's largest and one of the world's five largest shipbuilders. Aker Yards has a strong position both in terms of capacity, product range, technology and experience. The Company's product range includes offshore vessels, cruise and ferry vessels, other complex vessels and merchant vessels. The Group has 13 yards in four countries in Europe and in Brazil. Aker Yards had a turnover of NOK 16 bn. in 2003, and has approximately 14.500 employees.
Medi-Stim ASA to be admitted to the SMB List
The Board of Oslo Børs agreed to admit shares in Medi-Stim ASA to listing on the SMB List of Oslo Børs. The Board’s approval is conditional on the company achieving a satisfactory spread of shareholding in terms of the number of shareholders holding at least one round lot, as well as a satisfactory degree of free float in its shares. The Board authorised the President of Oslo Børs to decide the date of the first day of listing, which is to be no later than 16 June 2004.
About Medi-Stim
Medi-Stim ASA is a worldwide leading supplier of quality control procedures for cardiovascular surgery. Cardiovascular deseases is the most common cause of death in the western world. There are app. 730.000 cardiac- and 600.000 vascular surgical procedures performed globally per year. Medi-Stim has a leading position within quality control of cardiac surgery with app. 13 per cent marketpenetration. Sales in 2003 was mNOK 63 with an operating result of mNOK11,2. The most important markets for Medi-Stim are USA, Europe and Japan.
AXXESSIT ASA to be admitted to the SMB List
The Board of Oslo Børs agreed to admit shares in AXXESSIT ASA to listing on the SMB List of Oslo Børs. The Board’s approval is conditional on the company producing a listing prospectus for approval by Oslo Børs. The Board authorised the President of Oslo Børs to decide the date of the first day of listing, which is to be no later than 16 June 2004.
About AXXESSIT
AXXESSIT develops, produces and markets solutions that the telecom operators use in order to construct access networks. The solutions are based on the Multi-Service Provisioning Platform that handles both traditional telecom traffic (TDM) and data traffic (IP) for transport through SDH networks (next generation SDH solutions). Axxessit has more than 25 years of experience in telecom. AXXESSIT employs 170 people and has offices in Oslo, Bergen, Halden, Frankfurt, Warsaw and London.
